Omnicell, Inc.
Jul 21, 2017

Omnicell to Release Second Quarter 2017 Earnings Results on July 27, 2017

MOUNTAIN VIEW, Calif., July 21, 2017 /PRNewswire/ -- Omnicell, Inc. (NASDAQ: OMCL), a leading provider of medication and supply management solutions and analytics software for healthcare facilities, will hold a conference call on Thursday, July 27, 2017, to discuss the Company's second Quarter 2017 financial results. 

Omnicell, Inc. logo. (PRNewsFoto/Omnicell, Inc.)

 

What: 

Omnicell Second Quarter 2017 earnings conference call and webcast

When:  

July 27, 2017, 1:30 p.m. PT

Who: 

Randall Lipps, chairman, president and chief executive officer


Peter Kuipers, chief financial officer

Where:

The conference call can be monitored by dialing 1-800-696-5518 within the U.S. or 1-706-758-4883 for all other locations. The Conference ID # is 36566159.


The webcast can be accessed at: http://ir.omnicell.com/events.cfm.



How:    

Link to the Omnicell website 15 minutes prior to the call to download necessary audio software.

Replay:

Available starting at 4:30 p.m. PT on July 27, 2017 through 11:59 p.m. PT on            

August 25, 2017. Dial 1-855-859-2056 within the U.S. and 1-404-537-3406 for all other locations, Conference ID # 36566159.

About Omnicell

Since 1992, Omnicell (NASDAQ: OMCL) has been inspired to create safer and more efficient ways to manage medications and supplies across all care settings. As a leader in medication and supply dispensing automation, central pharmacy automation, IV robotics, analytics software, and medication adherence and packaging systems, Omnicell is focused on improving care across the entire healthcare continuum—from the acute care hospital setting, to post-acute skilled nursing and long-term care facilities, to the patient's home.

Over 4,000 customers worldwide use Omnicell® automation and analytics solutions to increase operational efficiency, reduce medication errors, deliver actionable intelligence and improve patient safety.

Omnicell's innovative medication adherence solutions, used by over 32,000 institutional and retail pharmacies in North America and the United Kingdom, are designed to improve patient adherence to prescriptions, helping to reduce costly hospital readmissions.

Recent Omnicell acquisitions, including Ateb, add distinct capabilities, particularly in central pharmacy, IV robotics, and pharmacy software, creating the broadest medication management product portfolio in the industry.

OMCL-E

 

View original content with multimedia:http://www.prnewswire.com/news-releases/omnicell-to-release-second-quarter-2017-earnings-results-on-july-27-2017-300492179.html

SOURCE Omnicell, Inc.

News Provided by Acquire Media